The Macrae Foundation will hold their annual International Symposium on Respiratory Viral Infections on March 14-17, 2013 in the Van der Valk Hotel Rotterdam-Blijdorp chaired by Albert D.M.E. Osterhaus, Professor of Virology, Erasmus MC and CSO of Viroclinics Biosciences in Rotterdam and Menno de Jong, Professor, Academic Medical Center, in Amsterdam. Viroclinics will be one of the sponsors of the Symposium.
Collaborative exchange of scientific information
"The symposium brings together international thought leaders, performing visionary research and developing current treatments that benefit everyone in the health science field," said Professor Albert Osterhaus, mentor for over 50 students, author of over 1,000 academic articles, creator of biotech companies like Viroclinics and holder of several editorial positions. "Practical aspects of current treatment will be present and future prospects for respiratory viral infectious diseases through invited talks and poster abstract presentations."
Viroclinics Biosciences participated in and was one of the sponsors for the Macrae Foundation's XIV International Symposium on Respiratory Viral Infections which was held on 23-26 March, 2012 in Istanbul, Turkey. This resulted in a great success and brought the company in contact with renowned scientists, developers and investigators from the respiratory disease field.
Supporting advance medical and scientific research in the field of infectious diseases
Bob van Gemen, CEO of Viroclinics Biosciences said: "It is a great opportunity to promote our company on a renowned international virology symposium which will be held in Rotterdam, The Netherland where we have our headquarter."
"We hope to meet a lot of our relations at the Macrae Foundation's XV International Symposium on Respiratory Viral Infections in March 2013 in Rotterdam." said Hans Bunschoten, COO of Viroclinics. "And show them our new facilities and extended capabilities for delivering high quality laboratory service in clinical studies".
A consultative approach to drug and vaccine development
Viroclinics Biosciences B.V. is a preclinical service and clinical laboratory service company with a consultative approach. The close collaboration with the renowned Viroscience Lab of the Erasmus MC in Rotterdam allows the company to support customers with the best virological knowledge available. The company is frontrunner to improve human and animal health by serving the biopharmaceutical community with expert advice and best in class service for (pre)clinical drug development of antivirals, vaccines and additional treatments. All projects are performed in compliance with established international guidelines under an ISO 15189 accredited quality system.
SOURCE: Viroclinics Biosciences